BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-1780 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-1780\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07470983-452@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:HRS-1780: Phase 2 readout est. (NCT07470983)
DESCRIPTION:HRS-1780\, phase 2.\nStudy: A Phase II Clinical Study on the Ef
 ficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism\n
 Estimated primary completion: November 2026. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/hrs-1780#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07470983
URL:https://assetmemo.bio/drug/hrs-1780#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07708441-452@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20290430
DTEND;VALUE=DATE:20290501
SUMMARY:HRS-1780: Phase 2/3 readout est. (NCT07708441)
DESCRIPTION:HRS-1780\, phase 2/3.\nStudy: A Trial of HRS-1780 in Participan
 ts With Uncontrolled Hypertension or Resistant Hypertension.\nEstimated pr
 imary completion: April 2029. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/hrs-1780#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07708441
URL:https://assetmemo.bio/drug/hrs-1780#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07419828-452@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20300430
DTEND;VALUE=DATE:20300501
SUMMARY:HRS-1780: Phase 3 readout est. (NCT07419828)
DESCRIPTION:HRS-1780\, phase 3\, Chronic Kidney Disease.\nStudy: A Phase II
 I Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment o
 f Patients With Chronic Kidney Disease\nEstimated primary completion: Apri
 l 2030. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/hrs-1780#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07419828
URL:https://assetmemo.bio/drug/hrs-1780#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
